CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 237.39 | 207.88 | -276.97 | -249.16 | -412.5 | -129.85 |
Depreciation & Amortization | 17.8 | 18.81 | 23.39 | 23.74 | 15.67 | 10.67 |
Stock-Based Compensation | 5.08 | 4.12 | 7.7 | 9.19 | 14.96 | 14.24 |
Other Adjustments | -4.86 | 52 | 55.13 | 114.41 | -375.24 | 17.17 |
Change in Receivables | 25.58 | 11.47 | 9.75 | 18.47 | -16.68 | 15.33 |
Changes in Inventories | - | 0.59 | -47.94 | -47.85 | -227.46 | -8.33 |
Changes in Accounts Payable | -75.29 | -140.58 | -30.1 | -96.18 | 179.32 | 620.31 |
Changes in Other Operating Activities | -33.12 | -52.44 | -8.84 | -58.8 | 88.81 | -17.13 |
Operating Cash Flow | 204.08 | 101.85 | -267.89 | -286.18 | -733.13 | 522.4 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -7.04 | -14.32 | -52.32 | -88.02 | -124.22 | -36.33 |
Purchases of Intangible Assets | -0.89 | -4.13 | -2.88 | -5.2 | -3.68 | -11.02 |
Purchases of Investments | - | - | - | - | - | -1.16 |
Cash Acquisitions | - | - | - | -0.28 | - | - |
Other Investing Activities | - | - | - | - | - | 3.24 |
Investing Cash Flow | -7.94 | -18.44 | -55.2 | -93.5 | -127.9 | -45.27 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | - | - | - | - | - | 49.86 |
Long-Term Debt Repaid | - | - | - | - | -25 | -94.75 |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | -25 | -44.89 |
Issuance of Common Stock | - | - | 236.09 | 67.39 | 373.15 | 867.72 |
Net Common Stock Issued (Repurchased) | - | - | 236.09 | 67.39 | 373.15 | 867.72 |
Other Financing Activities | -5.26 | -5.11 | -5.19 | -4.22 | -3.18 | -3 |
Financing Cash Flow | -5.4 | -5.11 | 230.89 | 63.17 | 344.96 | 819.83 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | -0.57 | 1 | -1.15 | 0.84 | 4.94 | -5.05 |
Net Cash Flow | 190.75 | 78.29 | -92.19 | -316.5 | -516.07 | 1,297 |
Beginning Cash & Cash Equivalents | 202.52 | 402.45 | 495.8 | 811.46 | 1,323 | 30.68 |
Ending Cash & Cash Equivalents | 392.7 | 481.75 | 402.45 | 495.8 | 811.46 | 1,323 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | 197.04 | 87.54 | -320.21 | -374.2 | -857.35 | 486.07 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | 38.60% | 16.36% | -595.65% | -555.03% | -832.46% | 994.61% |
Free Cash Flow Per Share | 0.95 | 0.39 | -1.45 | -1.98 | -4.61 | 3.68 |
Levered Free Cash Flow | 112.98 | -8.76 | -392.98 | -516.14 | -504.6 | 395.17 |
Unlevered Free Cash Flow | 152.86 | 33.61 | -406.81 | -516.7 | -480.93 | 458.75 |